Home » Health News » Ocugen says Indian partner's vaccine 93.4% effective against severe COVID-19

Health News

Ocugen says Indian partner's vaccine 93.4% effective against severe COVID-19

Forest Hayes July 2, 2021
FILE PHOTO: Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech’s COVID-19 vaccine called COVAXIN, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi

(Reuters) – The COVID-19 vaccine developed by Ocugen Inc’s Indian partner, Bharat Biotech, has been found to be 93.4% effective against severe cases of COVID-19 in a late-stage trial, the U.S. drug developer said on Friday.

Source: Read Full Article

Related posts:
  1. As COVID-19 cases fall, Mexican capital to allow open-air events
  2. Russia reports 8,329 new COVID-19 cases, 370 deaths
  3. Russian firm awaits government approval to ship remdesivir to India
  4. Portugal's COVID-19 state of emergency to end Friday -president